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ABSTRAK
Levonorgestrel (LNG) sememangnya dikenali sebagai pil pencegahan kehamilan 
kecemasan (EC) yang selamat and berkesan. Namun begitu, kes kehamilan luar 
rahim akibat daripada kegagalan LNG EC pernah dilaporkan. Insiden kehamilan 
luar rahim yang tepat sukar ditentukan akibat kemudahan untuk mendapatkan 
LNG EC daripada farmasi tanpa preskripsi. Kami melaporkan satu kes kehamilan 
luar rahim seorang pesakit perempuan tidak berkahwin yang berumur 18 tahun. 
Beliau telah mengambil LNG EC dalam jangkamasa 48 jam selepas persetubuhan. 
Beliau dihantar ke jabatan kecemasan pada minggu kelapan tempoh hamil dengan 
abdomen akut dan renjatan hipovolemik. Pembedahan laparotomi mengesahkan 
kehamilan di luar rahim yang sudah pecah di bahagian tiub fallopio dan 
salpingektomi telah dilaksanakan. Pesakit tersebut dibenarkan pulang selepas dua 
hari. Kami ingin menekankan kesan sampingan dan membincangkan perkaitan 
kehamilan luar rahim selepas penggunaan LNG EC.
Kata kunci: Levonorgestrel, pil pencegahan kehamilan kecemasan, kehamilan luar 
rahim
ABSTRACT
Levonorgestrel (LNG) is a well-known safe and efficacious emergency contraception 
(EC). However, ectopic pregnancy following the failure of LNG-only EC has been 
reported. The exact incidence of ectopic pregnancy has been hindered by lack 
of data due to the fact that LNG-only EC is accessible at pharmacies without a 
prescription. We describe a case of ectopic pregnancy in an 18 year-old single 
woman who took LNG-only EC within 48 hours of unprotected sexual intercourse. 
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She presented to the emergency department at 8 weeks period of amenorrhoea 
with an acute abdomen and hypovolaemic shock. Laparotomy confirmed a 
ruptured right tubal pregnancy and salpingectomy was performed. The patient was 
discharged well after 2 days. We aim to highlight this potential adverse effect and 
to discuss the plausible causality of ectopic pregnancy following administration of 
LNG-only EC. 
Key words: Levonogrestrel, emergency contraception, ectopic pregnancy
INTRODUCTION
Emergency contraception (EC) is 
defined as any drug or device used as 
an emergency measure to prevent an 
unplanned pregnancy after unprotected 
sexual intercourse or a known 
contraceptive failure (Cheng et al. 2004; 
Gemzell-Danielsson 2010). Currently, 
Levonorgestrel-only EC is recognized 
as a well-established EC (Gemzell-
Danielsson 2010). 1.5 mg Levonorgestrel 
(LNG) should be administered within 
72 hours after an unprotected sexual 
intercourse, either in a single dose or in 
two doses of 0.75 mg 12 hours apart 
(Cheng et al. 2004). The effectiveness 
of LNG as EC had been estimated to 
be between 57-95% depending on 
the delay of administration, highest 
when administered within 24 hours 
(Mikolajczyk & Stanford 2007; Gemzell-
Danielsson 2010; Kozinszky et al. 2011). 
However, the risk of ectopic pregnancy 
should be considered following LNG-
only EC failure. Numerous cases of 
ectopic pregnancy after the use of LNG-
only EC had been previously reported 
(Sheffer-Mimouni et al. 2003; Ghosh et 
al. 2009; Kozinszky et al. 2011). There 
was a rate of 4.1% ectopic pregnancies 
following failure of LNG-only EC, which 
was higher than the incidence of 1.1% 
to 1.6% in spontaneous pregnancies 
(Varma & Gupta 2009; Gainer et al. 
2001).
CASE REPORT
A healthy 18-year-old sexually active 
nulliparous woman presented to the 
emergency department with sudden 
onset of generalised abdominal pain 
associated with symptoms of severe 
anaemia at eight weeks period of 
amenorrhoea. Her menses were 
regular at 28 to 30 days per cycle. Urine 
pregnancy test was positive. She had no 
known risk factor for ectopic pregnancy. 
She did not practice any method of 
contraception. She provided a history 
of unprotected sexual intercourse 
approximately two weeks after her last 
normal menstrual period. Following 
the unprotected sexual intercourse, 
she took a course of LNG-only EC, 
2 doses of 0.75 mg 12 hours apart, 
with the first dose being administered 
within 48 hours. The LNG-only EC was 
purchased over the counter at a local 
pharmacy. She did not have any sexual 
intercourse consequently.  
 On assessment, she was in Stage 
III of hypovolaemic shock with severe 
pallor. Her blood pressure was 84/39 
mmHg and pulse 97/min. Abdomen 
was distended and guarded. Bimanual 
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examination revealed a uterus of 6 weeks 
size with bogginess at the pouch of 
Douglas. Transvaginal ultrasonography 
revealed an empty uterus with presence 
of large amounts of haemoperitoneum. 
She underwent a laparotomy and was 
found to have a ruptured right tubal 
pregnancy at the isthmus and a massive 
haemoperitoneum of 3000 ml. The left 
tube was normal. A right salpingectomy 
was performed. She was transfused 
with three pints of packed cells. The 
postoperative period was uneventful 
and she was discharged two days later 
with a haemoglobin level of 10.5 g/
dL. Histology of the surgical specimen 
confirmed a tubal pregnancy. 
DISCUSSION
The risk factors of tubal ectopic 
pregnancies include previous ectopic 
pregnancy, pelvic inflammatory disease, 
history of pelvic or tubal surgery, 
intrauterine contraceptive device use, 
salpingitis isthmica nodosa, infertility, 
smoking and assisted conception, 
although up to half of the women with 
ectopic pregnancies did not have any 
identifiable risk (Varma & Gupta 2009; 
Marion & Meeks 2012). However, the 
failure of emergency LNG-only EC had 
not been established as a risk factor 
for tubal ectopic pregnancy despite 
reported increased rate of ectopic 
pregnancy following its failure. 
 The mechanism of action of LNG-
only EC is not fully known but studies 
had shown that the mechanism of 
action and efficacy vary with phase of 
the menstrual cycle when the LNG EC 
was administered (Croxatto et al. 2003; 
Ghosh et al. 2009). The administration 
of LNG prior to the LH surge was able 
to inhibit or delay the LH surge, delay 
follicular development and arrest the 
unruptured follicles (Croxatto et al. 
2003; Gemzell-Danielsson 2010). 
Administration of LNG also transiently 
increased the viscosity of cervical 
mucus, which inhibited the passage 
of sperms (Noe et al. 2011). However, 
if taken when LH surge had already 
started, LNG is not able to prevent 
ovulation and hence, may be the cause 
for the reported failures using LNG 
EC (Croxatto et al. 2004). In addition, 
the administration of LNG during the 
peri- and postovulatory periods does 
not confer any significant change 
in the endometrial histology or any 
studied markers of receptivity during 
the mid-luteal phase at the expected 
time of endometrial receptivity and 
implantation (Ghosh et al. 2009; 
Gemzell-Danielsson 2010). It was 
concluded that LNG-only EC was 
highly effective in preventing pregnancy 
if administered prior to ovulation but 
if administered after ovulation, it was 
ineffective in preventing pregnancy, 
as it did not have any effect on the 
subsequent reproductive processes, 
including the implantation of the 
embryo (Noe et al. 2011). 
 Numerous studies had shown that 
the single dose of 1.5mg of LNG was 
equally as efficacious as two doses of 
0.75mg LNG as a mode of emergency 
contraception. In a review of emergency 
contraception, there was no evidence 
to indicate any difference in the rates of 
ectopic pregnancy between these two 
regimens (Cheng, et al. 2004).
 Smooth muscle contraction and 
ciliary activity of the fallopian tube 
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played an important role in the 
embryo-tubal transport, should 
fertilisation occur (Shaw et al. 2010). 
High levels of progesterone in the 
early luteal phase had been shown to 
reduce or slow ciliary activity in the 
fallopian tube and affect the embryo-
tubal transport (Paltieli et al. 2000; 
Gemzell-Danielsson 2010). Following 
the administration of two doses of 0.75 
mg LNG at 12 hours apart or a single 
dose of 1.5 mg of LNG, the serum level 
of LNG was high, reaching maximum 
levels of 25.3 nmol/L and 39.3 nmol/L 
respectively (Johansson et al. 2002). 
Theoretically, high levels of LNG would 
affect the motility of the tubes (Sheffer-
Mimouni et al. 2003). LNG was capable 
of markedly inhibiting the muscular 
contraction of the fallopian tube based 
on an in-vitro study (Wanggren et al. 
2008). The effect of LNG on the ciliary 
function and tubal muscular contraction 
could be the plausible explanation for 
the occurrence of ectopic pregnancy 
following emergency contraceptive 
failure. 
 There were three case reports on the 
failure of LNG-only EC administered 
during mid-cycle resulting in tubal 
ectopic pregnancies (Sheffer-Mimouni 
et al. 2003; Ghosh et al. 2009; Kozinszky 
et al. 2011). Camp et al. (2003) reported 
a rate of 7.4% (n = 21) of ectopic 
pregnancies from 285 pregnancies after 
the failure of LNG EC, while Gainer et 
al. (2001) reported a rate of 4.1% (n = 3) 
from a total of 73 pregnancies resulting 
from product failures (Camp et al. 2003; 
Gainer et al. 2001). However, there 
was no valid or unbiased assessment 
done and the authors did not rule out 
the possibility of unreported normal 
pregnancies following the product 
failure (Camp et al. 2003). A systematic 
review had shown that the rate of 
ectopic pregnancy following failure of 
LNG-only EC did not exceed the rate 
observed in spontaneous pregnancies 
as EC was effective in reducing 
risk of unwanted pregnancy and in 
turn, preventing ectopic pregnancy 
(Cleland et al. 2010). Nevertheless, 
the occurrence of ectopic pregnancy 
following the failure of LNG EC should 
not be disregarded. In comparison 
with the intrauterine devide (IUD), a 
meta-analysis of case-control studies 
reported that there is no increased risk 
of ectopic pregnancy with IUD use but 
a pregnancy with IUD in-situ is more 
likely to be an ectopic pregnancy. 
(Xiong et al. 1995).
CONCLUSION
This case report aims to highlight the 
occurrence of ectopic pregnancy 
following the failure of LNG-only EC 
despite being administered correctly. 
This is the first case being reported 
in Malaysia. Numerous case reports 
and literature had reported ectopic 
pregnancies after the use of LNG-only 
EC but it had not been statistically 
proven to be an established risk factor. 
This may be due to absence of an 
accurate method or research to report 
the exact incidence. However, as 
recent systematic reviews have failed 
to prove an increased risk of ectopic 
pregnancy following LNG-only EC 
compared to spontaneous conception, 
the public must not be misled into 
believing that there is an increased 
risk of ectopic pregnancy until there 
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is sufficient literature evidence. This 
is to avoid unnecessary fear to the 
usage of LNG-only EC causing a rise 
in occurence of unwanted pregnancies 
and baby abandonment which had 
been a disconcerting phenomenon in 
Malaysia recently.  
 Regulatory bodies in the UK, New 
Zealand and other countries have 
made recommendations to “consider 
the possibility” of ectopic pregnancy 
following the failure of LNG-only EC 
(Cleland et al. 2010). Therefore, both 
physicians and the public should be 
made aware of this adverse effect of 
LNG-only EC use. Prescription leaflets 
should contain information regarding 
ectopic pregnancy being one of the 
side effects of LNG EC use. In addition, 
physicians and pharmacists who 
prescribe the EC should educate the 
users to seek early consultation should 
there be presence of amenorrhoea 
for urine pregnancy test, menstrual 
abnormalities or abdominal pain 
following the administration. 
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